EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Surmodics's enterprise value is $412.0 Mil.
Surmodics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $121.6 Mil. Therefore, Surmodics's EV-to-Revenue for today is 3.39.
The historical rank and industry rank for Surmodics's EV-to-Revenue or its related term are showing as below:
SRDX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.45 Med: 4.65 Max: 12.71
Current: 3.39
During the past 13 years, the highest EV-to-Revenue of Surmodics was 12.71. The lowest was 2.45. And the median was 4.65.
SRDX's EV-to-Revenue is ranked worse than 53.23% of 821
companies
in the Medical Devices & Instruments industry
Industry Median: 3.12
vs SRDX: 3.39
As of today (2025-05-24), Surmodics's stock price is $28.70.
Surmodics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $8.55. Therefore, Surmodics's PS Ratio for today is 3.36.
Surmodics EV-to-Revenue Historical Data
The historical data trend for Surmodics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Surmodics's EV-to-Revenue
For the Medical Devices subindustry, Surmodics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surmodics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Surmodics's EV-to-Revenue falls into.
Surmodics's current Enterprise Value is $412.0 Mil.
Surmodics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $121.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surmodics's share price for today is $28.70.
Surmodics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.55.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surmodics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Surmodics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SRDX has been successfully added to your 